In collaboration with Stevenage Bioscience Catalyst, a panel of experienced entrepreneurs discuss the different ways that AI can be used to aid successful drug discovery and development, what is needed to optimize these various business models and ultimately how can companies mature innovation in this space to create patient impact faster.